Adagene Reports Full Year 2024 Financial Results and Provides Corporate Update
Muzastotug Phase 2 dose expansion in MSS CRC with a 20 mg/kg loading dose regimen shows 33% overall response rate...
Cancer
Cretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and Efficacy
– Latest BOND-003 data show 75.5% of patients achieved a complete response at any time –– Median duration of response...
Noah Medical’s Galaxy System Surpasses 5,000 Procedures, Marking a New Era in Robotic-Assisted Bronchoscopy
Milestone highlights rapid adoption of the Galaxy System’s advanced image-guided technology, transforming lung nodule diagnosis and patient careSAN CARLOS, Calif.,...
Allarity Therapeutics Launches Comprehensive Effort to Combat Potential Illegal Naked Short Selling of Its Shares
Boston (March 24, 2025)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage...
INmune Bio Inc. to Report Fourth Quarter 2024 Financial Results and Provide Corporate Update on March 27, 2025
Boca Raton, Florida, March 24, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and...
Tren-Max (Crazybulk) safe and legal steroid alternative to Trenbolone Acetate, Dosages Cycles Benefits and Guide to Buying Tren Ace, Tren Steroid For Sale!
NEW YORK, March 24, 2025 (GLOBE NEWSWIRE) -- “Tren-Max is the safe and legal steroid alternative to Trenbolone Acetate" Our...
Cyclacel Pharmaceuticals Announces $1 Million Private Placement Offering of Convertible Preferred Stock
KUALA LUMPUR, Malaysia, March 24, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. ("Cyclacel") (NASDAQ: CYCC, NASDAQ: CYCCP), a biopharmaceutical company...
Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2024 Financial Results and Webcast/Conference Call
MINNEAPOLIS, March 24, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies...
Moleculin Reports Full Year 2024 Financial Results and Provides Corporate Update
– Continued progress in pivotal, adaptive Phase 3 clinical trial (the “MIRACLE” trial) toward first subject treated, on track to...
Positive Data from Phase 1 Trial of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress
Clinical Complete Responses Observed with Single Low-Dose of Bel-sar in Patients with Intermediate and High-Risk NMIBC with Robust Cell-Mediated Immunity...
Chang Gung Memorial Hospital Advances Minimally Invasive Surgery with Robotic Technology
Achieves International Recognition with HIMSS Award for Excellence in Smart Healthcare TAOYUAN, March 23, 2025 /PRNewswire/ -- As the demand...
Leveling the Playing Field: Advocating for Women in Science & Research
NEW YORK, March 23, 2025 /PRNewswire/ -- Today Mediplanet launches their Women in Research campaign, aimed at addressing gender disparities in the...
Genmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc.
Company Announcement AbbVie Inc. files complaint against Genmab in the U.S. District Court for the Western District of Washington (Seattle)Genmab...
Johnson & Johnson Increases U.S. Investment to More than $55 Billion Over the Next Four Years
Investment builds on almost 140-year legacy of improving and saving lives and supporting American jobs Includes four planned new manufacturing...
Weekly Recap: 14 Health Press Releases You Need to See
A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including new semaglutide cardiovascular data and...
AI is here. NSU forum explores how it will change business, healthcare and everything else
NATCHITOCHES, La., March 21, 2025 /PRNewswire/ -- "AI works 120 million times faster than the human brain," according to Dr....
Noul Showcases AI-Powered Cervical Cancer Cell Screening Technology at NVIDIA GTC 2025
Company Joins NVIDIA Healthcare & Life Sciences (HCLS) Ecosystem to Advance Global Diagnostic Accessibility and Seeks Partnerships with Global Healthcare OpportunitiesYONGIN,...
EmpiRx Health Launches Weight Management Program to Help Improve Member Health Outcomes and Control Costs
New Clinically-Based Solution Integrates Weight Management Drug Therapies with Behavioral Change Management to Facilitate Member Success and Proactively Control Benefit...
Paradigm Health Announces Oncology and Healthcare Expert Dr. Karen E. Knudsen Appointed to Board of Directors and Launch of New AI-Driven Solution for Clinical Trial Data Collection and Management
COLUMBUS, Ohio, March 20, 2025 /PRNewswire/ -- Paradigm Health, which is rebuilding the clinical research ecosystem, today announced the appointment of...
Akari Therapeutics Appoints Biotechnology Industry Leader, Abizer Gaslightwala, as President and Chief Executive Officer
Former SVP and Franchise Head for US Oncology at Jazz Pharmaceuticals, with established track record for leading a portfolio of...